Briscoe M, Sykes R, Krystofiak T, et al. - Researchers undertook this longitudinal cohort study to determine whether Type 2 MI (myocardial Infarction)/Myocardial Injury are related to worse outcomes if complicated by Coronavirus disease 2019 (COVID‐19). They ascertained myocardial injury utilizing laboratory records as ≥ 1 hs‐TnI result > 99th percentile (men: >34 ng/L; women: >16 ng/L). As per the Fourth Universal Definition of Myocardial Infarction, endotypes were defined. PCR was used to ascertain COVID‐19. Less comorbidity, similar hs‐TnI levels, longer admission (days) and higher in‐hospital mortality were present in COVID‐19 patients. Experts found that typical manifestations of cardiac sequelae of COVID‐19 were Non‐cardiac myocardial injury/Type 2MI in younger patients with less co‐morbidity. Paradoxically, increased admission duration and in‐hospital mortality were seen.